Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population for the Chinese and what the relationship is between weight gain and the development of CHD or Type 2 diabetes risk in the Chinese population. It is this issue on which we focus in the present analysis.
Introduction
Coronary heart disease (CHD) and Type 2 diabetes are major health problems worldwide and are considered to be closely related to obesity (1, 2) . In the last 10 years both Type 2 diabetes and CHD have reached epidemic proportions in the mainland of China, although only a few Chinese meet the World Health Organization (WHO) criterion for obesity, i.e. a body mass index (BMI) of ≥30.0 kg m -2 . This raises the issue as to whether the WHO criteria for specifying overweight and obesity are suitable (LHDL); (4) hyperfibrinogenaemia (HFIB); and (5) Type 2 diabetes. Follow-up data from the major study were also used and relate to 629 non-diabetic subjects, 25-74 years of age, who were participants of an overall survey initially carried out in June 1985 (involving 110 660 adults aged 25-74 years: 55 391 men and 55 269 women) in Da Qing City, located in the Hei Longjiang province of northeast China. The non-diabetic group was not included in the dietary and/or exercise intervention study for the prevention of diabetes, which has been described in detail previously (3) . These 629 non-diabetics were sequentially assessed from 1986 to 1992. The effect of obesity on the development of Type 2 diabetes was investigated based on these follow-up data.
Subjects and methods
The distribution and clustering of CHD risk factors were specified on the basis of standardized abnormal levels, i.e. HP: >140/90 mmHg; HTG: ≥200 mg dL
; low HDL-C <40 mg dL -1 for men and <35 mg dL -1 for women; HFIB ≥400 mg dL ; and Type 2 diabetes using the specified 1985 criteria of the WHO. This clustering was assessed in 2856 subjects who were involved in a survey of essential hypertension in Da Qing in 1990. Blood pressure was measured twice by using a mercury sphygmomanometer after subjects had rested for 5 min (with monitoring) in the sitting position. The average of the two readings was recorded, with diastolic blood pressure (DBP) measured to the nearest 2 mmHg at the fifth Korotkoff sound. Blood for the determination of glucose, cholesterol (TC), triglyceride (TG), HDL-C and fibrinogen were collected into tubes containing EDTA. Plasma glucose was determined by the glucose oxidase method, and plasma TC and TG were measured by using an autoanalyser and cholesterol extraction and enzymatic methods. HDL cholesterol was determined in the supernatant after precipitation of very low density lipoproteins (VLDL) and low density lipoproteins (LDL) in plasma with manganese chloride and sodium heparin (4-6). Fibrinogen was determined by using the diurea method.
Statistical analysis was performed by using SAS software. Logistic regression analysis was used to assess the relationship between the waist circumference and risk factors for CHD. Some variables, such as TG, HDL and fibrinogen, were log-transformed in order to improve their normal distribution.
Results
Figures 1 and 2 show the distributions of BMIs and waist circumferences in the men and women studied. It is evident that the BMI distributions are very similar in men and women, with ª45% of both men and women being overweight according to the WHO global criteria (7) but with a majority, i.e. ª60%, being overweight or obese according to the preliminary proposals for Asia based on a BMI cut-off point of ≥23 (8) . Figure 2 shows the distribution of waist circumferences, where it is evident that men tend to have larger waist measurements than women; few of either gender have waist measurements >100 cm.
All the risk factors seemed to increase progressively from the lowest BMI value of £21, but marked increases in risk factors seemed to occur at different degrees of overweight (see Table 1 ). There was also a marked difference in the prevalence of the different risk factors, with HP and HFIB being the two most prevalent risks. Compared with the group with a BMI of <21, the prevalence of HP in men increased from 11.9 to 22.4% in the group with a BMI of 23-25 and to 35.0% in the group with a BMI of 25-27. The corresponding increases in women were increases from 8.1% to 17.0% and 29.5%, respectively. HTG also increased from 2.8% to 9.1% and 16.0% in men and from 5.2% to 7.3% and 8.9% in women. In the more overweight men and women, i.e. those with a BMI of >27, HP and HTG increased further to ª40%, with HP occurring in 50% of women with BMI values of ≥29. The prevalence of Type 2 diabetes also increased significantly in men once the BMI rose above 25.0, but in women the increase seemed to be progressive throughout the 'normal' WHO BMI range, reaching a plateau of 5.1% once a BMI of 25 had been reached.
The clustering of risk factors for CHD also proved to be BMI-related (see Table 2 ). Hence, in both men and women the prevalence of having at least a single risk factor increased from one-third of subjects with BMI values of <21 to about two-thirds of subjects with BMI values of ≥29. By the time men or women had a BMI of ≥25, onesixth of individuals had two risk factors. The prevalence of three or more risk factors became apparent once BMIs were >27, but the prevalence was low, i.e. ª6%. The odds ratio of having two or more risk factors for CHD was 1.69 in the group with a BMI of 23-25 and 3.89, 5.07 and 7.24 in the higher BMI categories when these were compared with the BMI <23 group (see Table 3 ). Table 4 shows the incidence of Type 2 diabetes during a six-year follow-up period. The 629 individuals were also classified in terms of their original fasting plasma glucose levels and in each category there is a separate estimation of the interaction between BMI and the original fasting plasma glucose (FPG) in predicting the incidence of Type 2 diabetes. It is clear that there is a fourfold increase in the incidence of diabetes in those with a BMI of ≥27 compared to those with a BMI of <24 and, in addition to this BMIrelated progressive increase in risk of diabetes, there is also a marked association with the FPG. Therefore, only ª5% of individuals with BMI values of <24 and FPG levels of <90 mg dL Waist circumference and waist-to-hip ratio clearly important to try to establish which measure might be most valuable in relation to each of the risk factors. Tables 7,  8 and 9 therefore set out the stepwise statistical analysis of the impact of these variables considered as independent, with age and gender being taken into account in the regression analysis. The waist circumference was, in every case, the first variable to emerge in the model as the dominant influence on both systolic and diastolic blood pressure as well as on serum triglycerides. The BMI value also contributed, but the WHR either did not emerge as having any significance or only entered the analysis as the last of the variables to make a contribution. Similarly, when the clustering of risk factors for CHD was considered, based on whether or not there were two or more risk factors, again waist circumference was shown to be more important than WHR, but age and BMI also made a contribution (see Table 10 ).
Discussion
These data demonstrate that if the WHO approach to specifying obesity as a BMI of ≥30 is taken as an indication for therapeutic intervention, then the Chinese population will be ignored despite the profound relationship of weight gain to metabolic risk factors and the incidence of diseases such as Type 2 diabetes. This, in turn, will mean that the whole approach to combating the epidemic of adult chronic diseases such as hypertension, diabetes, coronary heart disease and stroke, will probably be neglected. It seems reasonable to conclude therefore that even if the WHO cut-off points prove of use to Caucasian societies, they are without use in a Chinese context. It has to be recognized, however, that the WHO cut-off points were derived predominantly from epidemiological studies on Caucasian populations. The present analysis is based on information obtained from a study in the community. The results demonstrate that there is substantial risk of CHD in adults with BMI values of ≥25. In Da Qing City, 45% of the population already have a BMI of ≥25 and half the adults have at least previously (3), revealed an incidence of Type 2 diabetes in subjects with BMIs of ≥27 which was fourfold higher than in those with BMIs of <24 and with FPG levels <105 mg dL -1 at baseline. This infers that if one were obesity reviews Weight-related diabetes and cardiovascular risks G. Li et al. 171 Table 6 Comparison of the number of coronary heart disease (CHD) risk factors (RF) in different body mass index (BMI) and waist circumference (WC) categories Risk factor number in men Risk factor number in women Gender and waist-to-hip ratio (WHR) did not enter the model at a P = 0.10 level; the variability explained by these three variables amounted to 76.7%.
one CHD risk factor. By the time the BMI had risen to ≥27, about one-third of the population had two or more CHD risk factors.
The six-year prospective study, undertaken as part of the overall Da Quing survey which has been described in detail wanting to designate a hazardous BMI level to be appropriately specified as 'obese' then perhaps a BMI of 27.0 rather than 30.0 should be chosen for the Chinese. A BMI range of 25-27, or even perhaps 23-27, might be defined as 'overweight'.
A number of studies have suggested that the central deposition of fat is more important as a predictor of CHD risk than generalized obesity. The use of a simple waist circumference measurement has also given a more reliable indication of excess intra-abdominal fat than the WHR (9-11). The present study confirms this view and indicates that the use of the waist circumference is particularly valuable because it shows an almost linear increase in risk of elevated metabolic risk factors and this linearity is clearer than that seen with BMI. The stepwise regression analysis also revealed that the waist circumference was the first to enter the model, with BMI then being seen as of additional value. Waist circumference made the greatest contribution, however, to predicting the probability of hypertension or high plasma triglyceride levels. There seems, on the basis of this analysis, little reason to continue to use the WHR as an index of risk. It is also interesting that waist measurements >80 cm accord with risks similar to those observed in the BMI ≥25 category, with a 90-cm waist circumference equating in risk terms to that predicted by a BMI of ≥27.
In conclusion, it is evident that the risk of both CHD and Type 2 diabetes are closely related to BMI and waist circumference in the Chinese population, but that this risk emerges rapidly with much smaller increases of BMI and waist circumferences than those evident in Caucasian populations. Waist circumference measurements seem to be the best marker, not only of central obesity but also of risk, and on this basis cut-off points of BMI 27 and waist circumference of 90 cm can be considered indicative of
